KENDRA WITT: Open Payments
NPI 1245857259 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 31 payments from 6 companies in 2025. Trend: 2023 $245 · 2024 $188 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $481 |
| Janssen Biotech, Inc. | 2 | $73 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| Celltrion USA Inc. | 1 | $19 |
| Madrigal Pharmaceuticals | 1 | $18 |
Products named: SKYRIZI, RINVOQ, TREMFYA, CREON, LINZESS, XIFAXAN, DUPIXENT, VIBERZI.
Industry payments across CA — which companies pay providers there.
